You are here: Industry Insights > COVID-19

News List

Kantaro Receives EUA for Semi-Quantitative COVID-19 Antibody Test Kit americanpharmaceuticalreview
December 14, 2020
Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG ...
IPA to train 10 lakh pharmacists for COVID-19 vaccinations expresspharma
December 14, 2020
The association has asked its 22 state branches to identify five thousand registered pharmacists each for training with an aim to create a national-level database of potential COVID-19 vaccinators.
Australia invests AUSD 4 mn for research with India on COVID-19 expresspharma
December 14, 2020
Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered.
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials expresspharma
December 14, 2020
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science & Technology.
Scientists find five key genes are linked to severe COVID-19 expresspharma
December 14, 2020
The genes - called IFNAR2, TYK2, OAS1, DPP9 and CCR2 – partially explain why some people become desperately sick with COVID-19.
Lilly announces 650,000 additional doses of neutralizing antibody bamlanivimab (LY-CoV555) purchased by U.S. government to treat COVID-19 worldpharmanews
December 11, 2020
The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's neutralizing antibody bamlanivimab (LY-CoV555) 700 mg.
Studies Reveal Potential Weaknesses in SARS-CoV-2 Infection prnewswire
December 11, 2020
A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.
Rich countries buy up majority of COVID-19 vaccine doses, People’s Vaccine Alliance says europeanpharmaceuticalreview
December 11, 2020
According to the alliance, 70 poor countries will only be able to vaccinate one in 10 people against COVID-19 next year after rich countries bought up most prophylactics.
FDA Authorizes First Direct-to-Consumer COVID-19 Test System americanpharmaceuticalreview
December 11, 2020
The U.S. Food and Drug Administration (FDA) authorized LabCorp’s Pixel COVID-19 Test Home Collection Kit for use by any individual 18 years and older without a prescription.
Indian researchers find new potential COVID-19 drug treatments expresspharma
December 11, 2020
One proposed cocktail, baloxavir marboxil, natamycin and RU85053, targets three viral proteins respectively, 3CL Main protease, papain-like protease and RdRp.